3D Medicines Inc. (HKG:1244)

Hong Kong · Delayed Price · Currency is HKD

3.150

-0.170 (-5.12%)

May 7, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Biopharmaceutical Research and Development	356.09M	445.65M	634.95M	567.39M	60.26M
Biopharmaceutical Research and Development Growth	-20.10%	-29.81%	11.91%	841.57%	-
Total	356.09M	445.65M	634.95M	567.39M	60.26M
Total Growth	-20.10%	-29.81%	11.91%	841.57%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Mainland China	356.09M	445.65M	634.95M	567.39M	60.26M
Mainland China Growth	-20.10%	-29.81%	11.91%	841.57%	-
Total	356.09M	445.65M	634.95M	567.39M	60.26M
Total Growth	-20.10%	-29.81%	11.91%	841.57%	-

Source: S&P Global Market Intelligence.